Detection of Differentially Expressed microRNAs in Serum of Pancreatic Ductal Adenocarcinoma Patients: miR-196a Could Be a Potential Marker for Poor Prognosis

被引:0
|
作者
Xiangyu Kong
Yiqi Du
Guokun Wang
Jun Gao
Yanfang Gong
Lei Li
Zhuo Zhang
Jiaqi Zhu
Qing Jing
Yongwen Qin
Zhaoshen Li
机构
[1] Second Military Medical University,Department of Gastroenterology, Changhai Hospital
[2] Second Military Medical University,Department of Cardiology, Changhai Hospital
来源
关键词
Pancreatic cancer; Serum microRNA; Biomarker; miR-196a;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:602 / 609
页数:7
相关论文
共 50 条
  • [21] Serum microRNA-196 and microRNA-200 in pancreatic ductal adenocarcinoma of patients with diabetes mellitus
    Skrha, Pavel
    Horinek, Ales
    Pazourkova, Eva
    Hajer, Jan
    Fric, Premysl
    Skrha, Jan
    Andel, Michal
    PANCREATOLOGY, 2016, 16 (05) : 839 - 843
  • [22] β6-Integrin Serves as a Potential Serum Marker for Diagnosis and Prognosis of Pancreatic Adenocarcinoma
    Lenggenhager, Daniela
    Bengs, Susan
    Fritsch, Ralph
    Hussung, Saskia
    Busenhart, Philipp
    Endhardt, Katharina
    Topfer, Antonia
    The, Frans Olivier
    Butikofer, Simon
    Gubler, Christoph
    Scharl, Michael
    Morell, Bernhard
    CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, 2021, 12 (08) : E00395
  • [23] Low expression of DDX5 is associated with poor prognosis in patients with pancreatic ductal adenocarcinoma
    Morimachi, Masashi
    Hirabayashi, Kenichi
    Takanashi, Yumi
    Kawanishi, Aya
    Saika, Tsubasa
    Ueyama, Yumiko
    Nakagohri, Toshio
    Nakamura, Naoya
    Suzuki, Hidekazu
    Kagawa, Tatehiro
    JOURNAL OF CLINICAL PATHOLOGY, 2021, 74 (11) : 741 - 745
  • [24] Elevated STMN1 Expression Correlates with Poor Prognosis in Patients with Pancreatic Ductal Adenocarcinoma
    Li, Jian
    Hu, Guohuang
    Kong, Fujiao
    Wu, Kemin
    Song, Kun
    He, Jianfeng
    Sun, Weijia
    PATHOLOGY & ONCOLOGY RESEARCH, 2015, 21 (04) : 1013 - 1020
  • [25] Radiographic duodenal invasion is associated with poor prognosis and early recurrence in patients with pancreatic ductal adenocarcinoma
    Miyazawa, Motoki
    Hirono, Seiko
    Kawai, Manabu
    Okada, Ken-ichi
    Kitahata, Yuji
    Motobayashi, Hideki
    Sato, Masatoshi
    Yoshimura, Tomohiro
    Ueno, Masaki
    Hayami, Shinya
    Miyamoto, Atsushi
    Shimizu, Atsushi
    Yamaue, Hiroki
    EJSO, 2023, 49 (10):
  • [26] High expression of RACK1 is associated with poor prognosis in patients with pancreatic ductal adenocarcinoma
    Han, Hailin
    Wang, Dongmei
    Yang, Maowu
    Wang, Shenhao
    ONCOLOGY LETTERS, 2018, 15 (02) : 2073 - 2078
  • [27] Increased PRIM2 Expression Associated With Poor Prognosis in Patients With Pancreatic Ductal Adenocarcinoma
    Yin, Jingyang
    Guo, Shixiang
    Yang, Jiali
    Xia, Renpei
    Wang, Huaizhi
    PANCREAS, 2025, 54 (01) : e11 - e17
  • [28] Overexpression of Yes Associated Protein 1, an Independent Prognostic Marker in Patients With Pancreatic Ductal Adenocarcinoma, Correlated With Liver Metastasis and Poor Prognosis
    Salcedo Allende, Maria Teresa
    Zenon-Medina, Jorge
    Hernandez, Javier
    Macarulla, Teresa
    Balsells, Joaquim
    Merino, Xavier
    Allende, Helena
    Tabernero, Josep
    Ramon y Cajal Agueras, Santiago
    PANCREAS, 2017, 46 (07) : 913 - 920
  • [29] FGFR3 Nuclear Translocation Contributes to Proliferative Potential and Poor Prognosis in Pancreatic Ductal Adenocarcinoma
    Zhou, Li
    Lu, Jun
    Liang, Zhi-Yong
    Zhou, Wei-Xun
    Jiang, Bo-Lun
    Wang, Yi-Zhi
    Liu, Cheng-Xi
    Huang, Bo-Wen
    You, Lei
    Guo, Jun-Chao
    PANCREAS, 2022, 51 (05) : 476 - 482
  • [30] Elevated miR-483-3p expression is an early event and indicates poor prognosis in pancreatic ductal adenocarcinoma
    Wang, Cuiping
    Sun, Yang
    Wu, Huanwen
    Yu, Shuangni
    Zhang, Li
    Meng, Yunxiao
    Liu, Mingyang
    Yang, Haiyan
    Liu, Pingping
    Mao, Xinxin
    Lu, Zhaohui
    Chen, Jie
    TUMOR BIOLOGY, 2015, 36 (12) : 9447 - 9456